Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease: An MR spectroscopy study

Stroke

Volumn 30, Issue 5, 1999, Pages 1033-1037

  Kario, Kazuomi ^a,c   Matsuo, Takefumi ^b   Hoshide, Satoshi ^a   Umeda, Yuji ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cerebral metabolism; Cerebrovascular disorders; Dementia, vascular; Nuclear magnetic resonance; Spectroscopy; Thrombin

Indexed keywords

ARGATROBAN; CREATINE; N ACETYLASPARTIC ACID; THROMBIN INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BRAIN METABOLISM; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; WHITE MATTER;

EID: 0032932417     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.5.1033     Document Type: Article

References (14)

1. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Relation between nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensives: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130-135.
2. Kario K, Matsuo T, Kobayashi H, Asada R, Matsuo M. "Silent" cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high lipoprotein (a) levels in elderly Japanese. Arterioscler Thromb Vasc Biol. 1996;16:734-741.
3. Kobayahi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor clinical stroke. Stroke. 1997;28:1932-1939.
4. Gurwitz D, Cunningham DD. Neunte outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombi inhibition. J Cell Physiol. 1990;142:155-162.
5. Grand RJ, Grabham PW, Gallimore MJ, Gallimore PH. Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J. 1989;8: 2209-2215.
6. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci. 1997;17:5316-5326.
7. Smith MA, Perry G. Alzheimer disease: an imbalance of proteolytic regulation. Med Hypotheses. 1994;42:277-279.
8. Okamoto S, Hijikata A, Kikumoto R, Tonomura S, Hara H, Ninomiya K, Maruyama A, Sugano M, Tamao Y. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805: the importance of stereo-structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun. 1981;101:440-446.
9. Matsuo T, Koide M, Kario K. Development of argatroban, a direct thrombin inhibitor, and its clinical application. Semin Thromb Hemost. 1997;23:517-522.
10. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke. 1997; 28:1940-1943.
11. Matsuo T, Kario K, Matsuda S, Yamaguchi N, Kakishita E, for Hyogo Argatroban Research Group. Effect of thrombin inhibition on patients with peripheral arterial obstructive disease: a multicenter clinical trial of argatroban. J Thromb Thrombolysis. 1995;2:131-136.
12. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology. 1997;203:829-836.
13. 1H-MRS, MRI-based hippocampal volumetry, and 99 mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc. 1996;44:133-138.
14. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscope findings after acute cerebral infarction. Stroke. 1995;26:225-229.